Skip to main content
Clinical Trials/NCT01569347
NCT01569347
Completed
Not Applicable

Multicentric Descriptive Cross-sectional Study Evaluating Cocaine Users in Treatment Center

Assistance Publique - Hôpitaux de Paris1 site in 1 country417 target enrollmentApril 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cocaine-induced Psychotic Disorder During Intoxication
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
417
Locations
1
Primary Endpoint
causes and protective factors of Cocaine Induced Psychosis CIP
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim of this study is to determine the clinical, genetic and environmental factors associated with the phenotype "severe psychotic symptoms" caused by cocaine.

Detailed Description

The second purpose is to include gene x environment interaction and to analyse the factors associated with the presence or the absence of severe psychotic symptoms induced by cocaine.

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
November 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

causes and protective factors of Cocaine Induced Psychosis CIP

Time Frame: up to one day after taking cocaine

1. clinical data 2. biologic data 3. genetic data

Secondary Outcomes

  • gene, environment interactions associated with CIP(up to one day after taking cocaine)

Study Sites (1)

Loading locations...

Similar Trials